National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 5) (PB 59 of 2018) (Cth)

Case

PB 59 of 2018

National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 5)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated       27   June 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Part 1         Preliminary

  1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 5).

(2)   This Determination may also be cited as PB 59 of 2018.

  1. Commencement

This Determination commences on 1 July 2018.

  1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Amino acids – synthetic, formula

Omit

Amphotericin

Insert

Amphotericin B

[2]     Schedule 1, after item dealing with Balsalazide

Omit

Bacillus Calmette and Guerin, Tice strain

Beclomethasone

Insert

Beclometasone

[3]     Schedule 1, after item dealing with Benzathine benzylpenicillin

Omit

Benzhexol

Benztropine

Insert

Benzatropine

[4]     Schedule 1, after item dealing with Cabozantinib

Insert

Calcitonin salmon

[5]     Schedule 1, after item dealing with Chlorpromazine

Omit

Chlorthalidone

Cholestyramine

Insert

Chlortalidone

[6]     Schedule 1, after item dealing with Codeine

Insert

Colestyramine

[7]     Schedule 1, after item dealing with Desmopressin

Omit

Dexamphetamine

Insert

Dexamfetamine

[8]     Schedule 1, after item dealing with Efavirenz

Omit

Eformoterol

[9]     Schedule 1, after item dealing with Essential amino acids formula with vitamins and minerals

Omit

Ethacrynic acid

Insert

Estriol

Insert

Etacrynic acid

[10]   Schedule 1, after item dealing with Fluorometholone

Omit

Flupenthixol Decanoate

Insert

Flupentixol decanoate

[11]   Schedule 1, after item dealing with Fondaparinux

Insert

Formoterol

[12]   Schedule 1, after item dealing with Heparin

Omit

Hexamine

[13]   Schedule 1, after item dealing with Hydroxyethyl starch 130/0.4

Omit

Hydroxyurea

Insert

Hydroxycarbamide

[14]   Schedule 1, after item dealing with Levonorgestrel

Omit

Lignocaine

Insert

Lidocaine

[15]   Schedule 1, after item dealing with Mesna

Insert

Methenamine

[16]   Schedule 1, after item dealing with Mupirocin

Insert

Mycobacterium bovis (Bacillus Calmette and Guerin), Tice strain

[17]   Schedule 1, after item dealing with Ocriplasmin

Omit

Oestriol

[18]   Schedule 1, after item dealing with Perhexiline

Omit

Pericyazine

Insert

Periciazine

[19]   Schedule 1, after item dealing with Phenelzine

Omit

Phenobarbitone

Insert

Phenobarbital

[20]   Schedule 1, after item dealing with Probenecid

Omit

Procaine penicillin

Insert

Procaine benzylpenicillin

[21]   Schedule 1, after item dealing with Ribavirin

Insert

Ribociclib

[22]   Schedule 1, after item dealing with Ruxolitinib

Omit

Salcatonin

[23]   Schedule 1, after item dealing with Tetrabenazine

Omit

Tetracosactrin

Insert

Tetracosactide

[24]   Schedule 1, after item dealing with Thiamine

Omit

Thioguanine

[25]   Schedule 1, after item dealing with Ticagrelor

Insert

Tioguanine

[26]   Schedule 1, after item dealing with Triglycerides – medium chain, formula

Insert

Trihexyphenidyl

[27]   Schedule 2, after item dealing with Adefovir

Omit

Adrenaline

Insert

Adrenaline (epinephrine)

[28]   Schedule 2, after item dealing with Amlodipine with valsartan and hydrochlorothiazide

Omit

Amoxycillin

Amoxycillin with clavulanic acid

Insert

Amoxicillin

Amoxicillin with clavulanic acid

[29]   Schedule 2, after item dealing with Bromocriptine

Omit

Budesonide with eformoterol

Insert

Budesonide with formoterol

[30]   Schedule 2, after item dealing with Cefaclor

Insert

Cefalexin

[31]   Schedule 2, after item dealing with Cefalotin

Insert

Cefazolin

[32]   Schedule 2, after item dealing with Celecoxib

Omit

Cephalexin

Cephazolin

[33]   Schedule 2, after item dealing with Chorionic gonadotrophin

Insert

Ciclosporin

[34]   Schedule 2, after item dealing with Clindamycin

Omit

Clomiphene

Insert

Clomifene

[35]   Schedule 2, after item dealing with Cromoglycic acid

Omit

Cyclosporin

[36]   Schedule 2, after item dealing with Esomeprazole

Omit

Esomeprazole and clarithromycin and amoxycillin

Insert

Esomeprazole and clarithromycin and amoxicillin

Insert

Estradiol

[37]   Schedule 2, after item dealing with Fosinopril with hydrochlorothiazide

Omit

Frusemide

Insert

Furosemide

[38]   Schedule 2, after item dealing with Indapamide

Omit

Indomethacin

Insert

Indometacin

[39]   Schedule 2, after item dealing with Levodopa with carbidopa

Omit

Levonorgestrel with ethinyloestradiol

Insert

Levonorgestrel with ethinylestradiol

Insert

Levothyroxine

[40]   Schedule 2, after item dealing with Norethisterone

Omit

Norethisterone with ethinyloestradiol

Insert

Norethisterone with ethinylestradiol

[41]   Schedule 2, after item dealing with Octreotide

Omit

Oestradiol

[42]   Schedule 2, after item dealing with Somatropin

Omit

Sorbitol with sodium citrate and sodium lauryl sulfoacetate

Insert

Sorbitol with sodium citrate dihydrate and sodium lauryl sulfoacetate

[43]   Schedule 2, after item dealing with Terbinafine

Omit

Thyroxine

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0